#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.

POST Online Media Lite Edition


Cesca announces change in executive leadership

Staff writer |
Rancho Cordova, Ca., USA - October 30, 2014, Rancho Cordova, Ca., USA - Cesca Therapeutics Inc., an autologous cell-based regenerative medicine company, announced that Robin C. Stracey will serve as interim CEO pending the new hire.

Mr. Stracey was appointed to the Board of Directors in July 2011. He has been the President and Chief Executive Officer at both publicly-traded and privately held companies in the life sciences sector, including Integrated Fluidics, Inc., Cantimer Incorporated, and Applied Imaging Corporation.

Mr. Stracey has also held senior executive positions at Thermo Electron Corporation, now Thermo Fisher Scientific, and Dade Behring Inc., now Siemens Healthcare.


What to read next

Cesca Therapeutics adds Mark Bagnall to board
Arcadia Bio appoints Matthew Plavan as CFO
Cesca Therapeutics names Robin Stracey as CFO